Standard care plus infrascans
DeviceHourly infrascans to detect expanding intracranial hematomas
NCT Number: NCT04893837
MOBI-1 is a multicenter clinical trial that will evaluate the use of the Infrascanner for the monitoring of traumatic intracranial hematomas.
Looking for future studies?
Notify Me15 year and older
All sexes
Observational
UAB Hospital, Birmingham, Alabama, United States
MOBI-1 is a single-arm, multi-center derivation / validation study that will evaluate the use of the Infrascanner for monitoring traumatic intracranial hematomas. All patients will receive standard care plus hourly infrascanner assessments. This study will test the hypotheses that:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hourly infrascans to detect expanding intracranial hematomas
Time frame: Month 24
Number of participants whose Infrascan results were accurate
Time frame: 0-12 hours
Difference in time to detection of hematoma enlargement between Infrascan and second CT across the cohort
University of Alabama at Birmingham
Other
Acronym: MOBI-1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04111549
Brain Diseases, Brain Injuries
San Francisco, California, United States
View Trial DetailsNCT04794894
Brain Diseases, Brain Injuries
Omaha, Nebraska, United States
View Trial DetailsNCT00178659
Brain Diseases, Brain Injuries
Houston, Texas, United States
View Trial DetailsNCT05665764
Brain Diseases, Brain Injuries
Aurora, Colorado, United States
View Trial Details